日
関

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2014/04/12 01:39:52」(JST)

wiki en

Glycosyltransferases (abbre. GTFs, Gtfs) are enzymes (EC 2.4) that establish natural glycosidic linkages, including the biosynthesis of disaccharides, oligosaccharides and polysaccharides. They catalyse the transfer of monosaccharide moieties from activated nucleotide sugar (also known as the "glycosyl donor") to a glycosyl acceptor molecule, usually an alcohol.

The result of glycosyl transfer can be a carbohydrate, glycoside, oligosaccharide, or a polysaccharide. Some glycosyltransferases catalyse transfer to inorganic phosphate or water. Glycosyl transfer can also occur to protein residues, usually to tyrosine, serine, or threonine to give O-linked glycoproteins, or to asparagine to give N-linked glycoproteins. Mannosyl groups may be transferred to tryptophan to generate C-mannosyl tryptophan, which is relatively abundant in eukaryotes. Transferases may also use lipids as an acceptor, forming glycolipids, or even lipid-linked sugar phosphate donors, such as dolichol phosphates.

It is common that sugar nucleotide derivatives are used as glycosyl donors. Glycosyltransferases that use sugar nucleotides are called Leloir enzymes, after Luis F. Leloir, the scientist who discovered the first sugar nucleotide and who received the 1970 Nobel Prize in Chemistry for his work on carbohydrate metabolism.

Glycosyltransferases that utilize non-nucleotide donors, which may be polyprenol pyrophosphates, polyprenol phosphates, sugar-1-phosphates, or sugar-1-pyrophosphates, are termed non-Leloir glycosyltransferases. Such non-Leloir enzymes occur in a variety of organisms.

Mechanism

Associative mechanisms utilized by retaining and inverting glycosyltransferases

Glycosyltransferases catalyse the transfer of activated carbohydrate moieties from donor molecules (e.g. UDP-Galactose) to an acceptor molecule. The acceptor substrate of a glycosyltransferase may be as simple as a second monosaccharide or very complex. Acceptors may be carbohydrate, nucleic acid, lipid, protein or of other chemical nature.

Mammals utilize only 9 sugar nucleotide donors for glycosyltransferases:^[1] UDP-glucose, UDP-galactose, UDP-GlcNAc, UDP-GalNAc, UDP-xylose, UDP-glucuronic acid, GDP-mannose, GDP-fucose, and CMP-sialic acid. The phosphate(s) of these donor molecules are coordinated to the enzymes by divalent cations such as manganese, however other organisms may have metal independent enzymes and may utilize many other nucleotide sugar donors.

Some glycosyltransferases use lipid-linked glycosyl donors, frequently a terpenoid such as dolichol or polyprenol.

Glycosyltransferases can be segregated into “retaining” or“ inverting” enzymes according to whether the stereochemistry of the donor’s anomeric bond is retained (α→α) or inverted (α→β) during the transfer. The inverting mechanism is straight forward, requiring a single nucleophilic attack from the accepting atom to invert stereochemistry. The retaining mechanism has been a matter of debate, but there exists strong evidence against a double displacement mechanism (which would cause two inversions about the anomeric carbon for a net retention of stereochemistry) or a dissociative mechanism (a popular variant of which was known as SNi). An “orthogonal associative” mechanism has been proposed which, akin to the inverting enzymes, requires only a singlenucleophilic attack from an acceptor from a non-linear angle (as observed in many crystal structures) to achieve anomer retention.^[2]

Classification by sequence

Sequence-based classification methods have proven to be a powerful way of generating hypotheses for protein function based on sequence alignment to related proteins. The carbohydrate-active enzyme database presents a sequence-based classification of glycosyltransferases into over 90 families.^[3] The same three-dimensional fold is expected to occur within each of the families.^[4]

Structure

In contrast to the diversity of 3D structures observed for glycoside hydrolases, glycosyltransferase have a much smaller range of structures. In fact, according to the Structural Classification of Proteins database, only three different folds have been observed for glycosyltransferases^[5] Very recently, a new glycosyltransferase fold was identified for the glycosyltransferases involved in the biosynthesis of the NAG-NAM polymer backbone of peptidoglycan.^[6]

Inhibitors

Many inhibitors of glycosyltransferases are known. Some of these are natural products, such as moenomycin, an inhibitor of peptidoglycan glycosyltransferases, the nikkomycins, inhibitors of chitin synthase, and the echinocandins, inhibitors of fungal b-1,3-glucan synthases. Some glycosyltransferase inhibitors are of use as drugs or antibiotics. Moenimycin is used in animal feed as a growth promoter. Caspofungin has been developed from the echinocandins and is in use as an antifungal agent. Ethambutol is an inhibitor of mycobacterial arabinotransferases and is used for the treatment of tuberculosis. Lufenuron is an inhibitor of insect chitin synthases and is used to control fleas in animals.

Determinant of blood type

The ABO blood group system is determined by what type of glucosyltransferases are expressed in the body.

The ABO gene locus expressing the glucosyltransferases has three main alleleic forms: A, B, and O. The A allele encodes a glycosyltransferase that bonds α-N-acetylgalactosamine to D-galactose end of H antigen, producing the A antigen. The B allele encodes a glycosyltransferase that joins α-D-galactose bonded to D-galactose end of H antigen, creating the B antigen. In case of O allele the exon 6 contains a deletion that results in a loss of enzymatic activity. The O allele differs slightly from the A allele by deletion of a single nucleotide - Guanine at position 261. The deletion causes a frameshift and results in translation of an almost entirely different protein that lacks enzymatic activity. This results in H antigen remaining unchanged in case of O groups.

The combination of glucosyltransferases by both alleles present in each person determines whether there is an AB, A, B or O blood type.

Uses

Glycosyltransferases have been widely used in the synthesis of glycoconjugates. Suitable enzymes can be isolated from natural sources or produced recombinantly. As an alternative, whole cell-based systems utilizing either endogenous glycosyl donors or cell-based systems containing cloned and expressed systems for synthesis of glycosyl donors have been developed. In cell-free approaches, the large-scale application of glycosyltransferases for glycoconjugate synthesis has required access to large quantities of the glycosyl donors. On the flip-side, nucleotide recycling systems that allow the resynthesis of glycosyl donors from the released nucleotide have been developed. The nucleotide recycling approach has a further benefit of reducing the amount of nucleotide formed as a by-product, thereby reducing the amount of inhibition caused to the glycosyltransferase of interest – a commonly observed feature of the nucleotide byproduct.

References

^ Etzler ME, Varki A, Cummings RL, Esko JD, Freeze HH, Hart GW, ed. (2008). Essentials of Glycobiology (2nd ed.). Plainview, N.Y: Cold Spring Harbor Laboratory Press. ISBN 0-87969-770-9.
^ Schuman B, Evans SV, Fyles TM (August 2013). "Geometric Attributes of Retaining Glycosyltransferase Enzymes Favor an Orthogonal Mechanism". PLoS ONE 8 (8): e71077. doi:10.1371/journal.pone.0071077.
^ CAZypedia Glycosyltransferases
^ CAZy Glycosyl Transferase
^ SCOP: Structural Classification of Proteins
^ Lovering AL, de Castro LH, Lim D, Strynadka NC (March 2007). "Structural insight into the transglycosylation step of bacterial cell-wall biosynthesis". Science 315 (5817): 1402–5. doi:10.1126/science.1136611. PMID 17347437.

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. B群レンサ球菌：病原性因子および発症機序 group b streptococcus virulence factors and pathogenic mechanisms
2. 高リン血症の原因および治療の概要 overview of the causes and treatment of hyperphosphatemia
3. 幼児の肥厚性幽門狭窄症 infantile hypertrophic pyloric stenosis
4. 眼咽頭型、遠位型，および先天性筋ジストロフィー oculopharyngeal distal and congenital muscular dystrophies

English Journal

Expression profiling of the triterpene saponin biosynthesis genes FPS, SS, SE, and DS in the medicinal plant Panax notoginseng.

Niu Y, Luo H, Sun C, Yang TJ, Dong L, Huang L, Chen S.SourceThe National Engineering Laboratory for Breeding of Endangered Medicinal Materials, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100193, PR China.
Gene.Gene.2014 Jan 1;533(1):295-303. doi: 10.1016/j.gene.2013.09.045. Epub 2013 Sep 19.
Panax notoginseng (Burk) F. H. Chen, an economically significant medicinal plant with hemostatic and health tonic activities, has been used in Traditional Chinese Medicine (TCM) for more than 3000years. Triterpene saponins are responsible for most of the pharmacological activities of P. notoginseng.
PMID 24055483

Mowat-Wilson syndrome detected by using high resolution microarray.

Park JY, Cho EH, Lee EH, Kang YS, Jun KR, Hur YJ.SourceDepartment of Pediatrics, Inje University College of Medicine, Haeundae Paik Hospital, Busan, South Korea.
Gene.Gene.2013 Dec 15;532(2):307-9. doi: 10.1016/j.gene.2013.07.067. Epub 2013 Sep 9.
Individuals with Mowat-Wilson syndrome (MWS; OMIM#235730) have characteristic facial features, a variety of congenital anomalies such as Hirschsprung disease, and intellectual disabilities caused by mutation or deletion of ZEB2 gene. This deletion or cytogenetic abnormality has been reported primari
PMID 24029077

First functional analysis of a novel splicing mutation in the B3GALTL gene by an ex vivo approach in Tunisian patients with typical Peters plus syndrome.

Ben Mahmoud A, Siala O, Mansour RB, Driss F, Baklouti-Gargouri S, Mkaouar-Rebai E, Belguith N, Fakhfakh F.SourceLaboratoire de Génétique Moléculaire Humaine, Faculté de Médecine de Sfax, Université de Sfax, Tunisia. Electronic address: afifbenmahmoud@gmail.com.
Gene.Gene.2013 Dec 10;532(1):13-7. doi: 10.1016/j.gene.2013.07.058. Epub 2013 Aug 14.
Peters plus syndrome is a rare recessive autosomal disorder comprising ocular anterior segment dysgenesis, short stature, hand abnormalities and distinctive facial features. It was related only to mutations in the B3GALTL gene in the 13q12.3 region. In this study, we undertook the first functional a
PMID 23954224